PEAK6 Investments’s BioTelemetry, Inc. BEAT Stock Holding History

PEAK6 Investments’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-6,910	Closed	-$362K	–	5420
2020 Q3	$315K	Sell	6,910 -66,043	-91%	-$2.76M	﹤0.01%	3189
2020 Q2	$3.3M	Sell	72,953 -2,731	-4%	-$122K	0.01%	1096
2020 Q1	$2.92M	Buy	+75,684	New	+$3.48M	0.02%	799
2019 Q4	–	Sell	-26,673	Closed	-$1.16M	–	4397
2019 Q3	$1.09M	Buy	+26,673	New	+$1.15M	0.01%	1707

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

PEAK6 Investments's BEAT Position: Q4 2020 in Review

PEAK6 Investments sold out of BioTelemetry, Inc. (BEAT) in Q4 2020, closing a stake of 6,910 shares — an estimated $362K sold.

PEAK6 Investments first reported a position in BEAT in Q3 2019 and held it in 4 quarters. The position peaked at $3.3M in Q2 2020. 238 funds tracked by Wall St. Rank hold BEAT as of Q4 2020.

PEAK6 Investments reported no remaining BioTelemetry, Inc. position as of Q4 2020 after selling out during the quarter.
PEAK6 Investments sold 6,910 BioTelemetry, Inc. shares in Q4 2020, an estimated $362K.
PEAK6 Investments first reported a position in BioTelemetry, Inc. in Q3 2019 and held it in 4 quarters.
PEAK6 Investments's BioTelemetry, Inc. position peaked at $3.3M in Q2 2020.
238 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2020.

Based on PEAK6 Investments's 13F filing for Q4 2020, filed 12 Feb 2021.